287 related articles for article (PubMed ID: 35156529)
1. MeCP2-induced heterochromatin organization is driven by oligomerization-based liquid-liquid phase separation and restricted by DNA methylation.
Zhang H; Romero H; Schmidt A; Gagova K; Qin W; Bertulat B; Lehmkuhl A; Milden M; Eck M; Meckel T; Leonhardt H; Cardoso MC
Nucleus; 2022 Dec; 13(1):1-34. PubMed ID: 35156529
[TBL] [Abstract][Full Text] [Related]
2. Rett syndrome-causing mutations compromise MeCP2-mediated liquid-liquid phase separation of chromatin.
Wang L; Hu M; Zuo MQ; Zhao J; Wu D; Huang L; Wen Y; Li Y; Chen P; Bao X; Dong MQ; Li G; Li P
Cell Res; 2020 May; 30(5):393-407. PubMed ID: 32111972
[TBL] [Abstract][Full Text] [Related]
3. MeCP2 Rett mutations affect large scale chromatin organization.
Agarwal N; Becker A; Jost KL; Haase S; Thakur BK; Brero A; Hardt T; Kudo S; Leonhardt H; Cardoso MC
Hum Mol Genet; 2011 Nov; 20(21):4187-95. PubMed ID: 21831886
[TBL] [Abstract][Full Text] [Related]
4. MeCP2 heterochromatin organization is modulated by arginine methylation and serine phosphorylation.
Schmidt A; Frei J; Poetsch A; Chittka A; Zhang H; Aßmann C; Lehmkuhl A; Bauer UM; Nuber UA; Cardoso MC
Front Cell Dev Biol; 2022; 10():941493. PubMed ID: 36172281
[TBL] [Abstract][Full Text] [Related]
5. Heterochromatin organization and phase separation.
Zhang H; Qin W; Romero H; Leonhardt H; Cardoso MC
Nucleus; 2023 Dec; 14(1):2159142. PubMed ID: 36710442
[TBL] [Abstract][Full Text] [Related]
6. MECP2, a multi-talented modulator of chromatin architecture.
Della Ragione F; Vacca M; Fioriniello S; Pepe G; D'Esposito M
Brief Funct Genomics; 2016 Nov; 15(6):420-431. PubMed ID: 27296483
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 and Chromatin Compartmentalization.
Schmidt A; Zhang H; Cardoso MC
Cells; 2020 Apr; 9(4):. PubMed ID: 32260176
[TBL] [Abstract][Full Text] [Related]
8. MeCP2 binds to methylated DNA independently of phase separation and heterochromatin organisation.
Pantier R; Brown M; Han S; Paton K; Meek S; Montavon T; Shukeir N; McHugh T; Kelly DA; Hochepied T; Libert C; Jenuwein T; Burdon T; Bird A
Nat Commun; 2024 May; 15(1):3880. PubMed ID: 38719804
[TBL] [Abstract][Full Text] [Related]
9. Multivalent Peptide Ligands To Probe the Chromocenter Microenvironment in Living Cells.
Guidotti N; Eördögh Á; Mivelaz M; Rivera-Fuentes P; Fierz B
ACS Chem Biol; 2023 May; 18(5):1066-1075. PubMed ID: 35447032
[TBL] [Abstract][Full Text] [Related]
10. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
Martínez de Paz A; Ausió J
Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
[TBL] [Abstract][Full Text] [Related]
11. Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo.
Kumar A; Kamboj S; Malone BM; Kudo S; Twiss JL; Czymmek KJ; LaSalle JM; Schanen NC
J Cell Sci; 2008 Apr; 121(Pt 7):1128-37. PubMed ID: 18334558
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions underlying the phase separation of HP1α: role of phosphorylation, ligand and nucleic acid binding.
Her C; Phan TM; Jovic N; Kapoor U; Ackermann BE; Rizuan A; Kim YC; Mittal J; Debelouchina GT
Nucleic Acids Res; 2022 Dec; 50(22):12702-12722. PubMed ID: 36537242
[TBL] [Abstract][Full Text] [Related]
13. Liquid-Liquid Phase Separation of Histone Proteins in Cells: Role in Chromatin Organization.
Shakya A; Park S; Rana N; King JT
Biophys J; 2020 Feb; 118(3):753-764. PubMed ID: 31952807
[TBL] [Abstract][Full Text] [Related]
14. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.
Hansen JC; Ghosh RP; Woodcock CL
IUBMB Life; 2010 Oct; 62(10):732-8. PubMed ID: 21031501
[TBL] [Abstract][Full Text] [Related]
15. Neuronal non-CG methylation is an essential target for MeCP2 function.
Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
[TBL] [Abstract][Full Text] [Related]
16. MeCP2 dependent heterochromatin reorganization during neural differentiation of a novel Mecp2-deficient embryonic stem cell reporter line.
Bertulat B; De Bonis ML; Della Ragione F; Lehmkuhl A; Milden M; Storm C; Jost KL; Scala S; Hendrich B; D'Esposito M; Cardoso MC
PLoS One; 2012; 7(10):e47848. PubMed ID: 23112857
[TBL] [Abstract][Full Text] [Related]
17. Rett syndrome: a surprising result of mutation in MECP2.
Dragich J; Houwink-Manville I; Schanen C
Hum Mol Genet; 2000 Oct; 9(16):2365-75. PubMed ID: 11005791
[TBL] [Abstract][Full Text] [Related]
18. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T
Nat Genet; 2005 Jan; 37(1):31-40. PubMed ID: 15608638
[TBL] [Abstract][Full Text] [Related]
19. Targeted manipulation of heterochromatin rescues MeCP2 Rett mutants and re-establishes higher order chromatin organization.
Casas-Delucchi CS; Becker A; Bolius JJ; Cardoso MC
Nucleic Acids Res; 2012 Dec; 40(22):e176. PubMed ID: 22923521
[TBL] [Abstract][Full Text] [Related]
20. HP1β carries an acidic linker domain and requires H3K9me3 for phase separation.
Qin W; Stengl A; Ugur E; Leidescher S; Ryan J; Cardoso MC; Leonhardt H
Nucleus; 2021 Dec; 12(1):44-57. PubMed ID: 33660589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
